Collaborate with third parties
One aspect is sticking out when looking for common denominators in successful knowledge valorisation: collaboration and co-creation. Turning a scientific result into a practical application in whatever form is never a one-person or even a one-group effort. IXA can support you right from the start with finding the right partners, negotiating agreements and taking care of the formalities.
Finding partners
The IXA business developers can assist you in looking for partners with the expertise, skills and facilities that suit your needs. Your own contacts are a good starting point, which we complement with our broad network in the public and private sectors. Think of other academic research groups, companies, SMEs, NGOs, educational institutions, entrepreneurs, hospitals, government agencies and so forth. In particular noteworthy in this respect is that research results increasingly give rise to software. IXA has developed a checklist and flowchart for collaborating with software developers.
Negotiating an agreement
Negotiating an agreement that suits the interests of all parties involved can be challenging. Especially when commercial parties are involved, it is key to thoroughly prepare for discussions and negotiations. IXA gladly takes place at the table to assist you during the negotiations. This way, we can ensure that the interests of all parties involved are respected.
IXA’s negotiation support encompasses all type of agreements you may encounter as an entrepreneurial researcher. Find an overview of agreements on the Legal Matters page.
The formalities
Once dialogue with a third party has started, IXA can help you to deal with the formal aspects of closing collaboration agreements. We make sure the financial, IP- and other legal aspects of the contract are fully compliant with the policies and guidelines of your institution. Go to our Legal Matters page to read more about this process.
2016 AMSIA winner receives CE Mark for non-radioactive tumor localization system
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]
News
Alumni Joint Master Entrepreneurship (UvA/VU) often pursue entrepreneurial careers
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]
News
Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]
News